| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-11 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.27 | 6e-11 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.32 | 3e-08 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-08 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.2 | 9e-08 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 6e-07 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |